Here is why the Anchiano Therapeutics Ltd. (ANCN) stock has soared
Anchiano Therapeutics Ltd. (NASDAQ: ANCN) stock soared by 5.37% to the current price of $4.71. ANCN has finally merged with Chemomab Ltd. The reason for
Anchiano Therapeutics Ltd. (NASDAQ: ANCN) stock soared by 5.37% to the current price of $4.71. ANCN has finally merged with Chemomab Ltd. The reason for
On March 5, the American stock exchanges closed in the green zone. The S&P 500 rose 1.95% to 3842 points, the Dow Jones added 1.85%,
Sundial Growers Inc. (SNDL) stock soared 1.72% to $0.5088 in the pre-market trading after declaring $50 million prepayment on senior secured non-revolving term credit facility.
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.